Emerald Advisers, LLC Cardiff Oncology, Inc. Transaction History

Emerald Advisers, LLC

  • $2.41 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 29, 2021
SELL
$9.1 - $19.57 $1.95 Million - $4.2 Million
-214,376 Closed
0 $0
Q4 2020

Jan 29, 2021
SELL
$12.02 - $24.71 $1.74 Million - $3.58 Million
-144,959 Reduced 40.34%
214,376 $3.86 Million
Q3 2020

Oct 28, 2020
BUY
$4.25 - $14.19 $1.53 Million - $5.1 Million
359,335 New
359,335 $5.1 Million

Others Institutions Holding CRDF

# of Institutions
94
Shares Held
12.4M
Call Options Held
813K
Put Options Held
91.1K
View Full List

About Cardiff Oncology, Inc.

CRDF Quotes by TradingView
  • Ticker CRDF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,334,900
  • Market Cap $195M
  • Description
  • Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...
More about CRDF
Track This Portfolio

Track Emerald Advisers, LLC Portfolio

Follow Emerald Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email